
The Raw Nerve
Ep86 Funding the Future: The Next Generation of MS Research
Announced on 29 July , MS Australia's 2026 Mid-Year Research Grants support bold new ideas with the potential to transform the future of multiple sclerosis (MS) research and treatment . Every breakthrough in MS research begins with researchers asking questions yet to be answered. MS Australia is committed to supporting Australia’s leading researchers as they tackle some of the biggest unanswered questions in MS. In today’s episode, MS Australia’s Deputy Head of Research, Dr Fiona McKay, speaks with two of this year’s grant recipients: Dr Tal Koren from the Brain and Mind Centre at The University of Sydney and Dr Samantha Barton from The Florey Institute of Neuroscience and Mental Health in Melbourne. Dr Koren discusses his work using advanced MRI techniques and artificial intelligence to better detect and monitor spinal cord damage in people living with MS. Dr Barton explains how human stem cell-derived ‘mini brains’ are helping her team study myelin formation and identify future opportunities to repair damaged myelin. You’ll also hear about our third grant recipient, Dr Carla Proietti , whose research at The University of Queensland’s Institute for Molecular Bioscience investigates how Epstein-Barr virus (EBV) and genetics interact in MS , as well as details of MS Australia's National Symposium on MS Medications taking place later this year. The three innovative projects funded through MS Australia's 2026 Mid-Year Grant Round address our community’s top priorities for MS research , including causes and prevention, better treatments, and cures through cell repair and regeneration. Together, these projects explore the role of EBV and genes in MS, myelin in ‘mini brains’, and the use of AI for more sensitive MS monitoring. Join us to hear what these projects could mean for the future and what inspires and motivates this next generation of MS researchers.

